Winding-Up Petition

Hellenic Dynamics PLC
26 November 2024
 

26 November 2024

 

Hellenic Dynamics plc

 

("Hellenic Dynamics" or the "Company")

 

Winding-Up Petition

 

Hellenic Dynamics plc (LSE: HELD), a medical cannabis cultivator focused on producing medical cannabis flowers for global markets announces that on 1 November 2024 a petition for the compulsory liquidation of the Company was filed by a shareholder. The sum claimed in the petition as at the date of the petition is a total of £32,274.26. The petition is due to be heard in the High Court on 18 December 2024. It is the belief of the directors of the Company that this petition amounts to an abuse of the process of the High Court due to the fact that the petitioner is not a creditor of the Company and as such, the Company will be making an application to the High Court for the petition to be dismissed.

 

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. With the publication of this announcement, this information is now considered to be in the public domain.

The Directors of the Company take responsibility for this announcement.

 

Enquires:

 

Hellenic Dynamics Plc

Davinder Rai

+44 (0)20 3818 7850

info@hellenicdynamics.com

 

Cairn Financial Advisers LLP

Emily Staples / Jo Turner

+44 (0)20 7213 0880

 

 

Peterhouse Capital - Brokers

Lucy Williams / Charles Goodfellow

+44 (0)20 7469 0930

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100